Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RoSA: Revival of Autochthonous Adrenocortical Stem Cells
NCT01371526Phase 4Completed
- Sponsor
- Newcastle University
- Start
- Sep 2010
- Primary completion
- Sep 2012
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tetracosactide hexaacetate in primary adrenal insufficiency (PAI), sponsored by Newcastle University. Started Sep 2010; status: completed.
02
Drugs
tetracosactide hexaacetate
03
Conditions
primary adrenal insufficiency (PAI)
Beyond the preview
Go deeper on NCT01371526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01371526.